Comparison of Six Different Allergen Extracts for Subcutaneous Specific Immunotherapy in Children: An Open-Labelled, Prospective, Controlled Observational Trial

2019 ◽  
Vol 180 (4) ◽  
pp. 284-290
Author(s):  
Matthias Volkmar Kopp ◽  
Inke R. König ◽  
Frank Friedrichs ◽  
Hans Ulrich Umpfenbach ◽  
Bodo Niggemann ◽  
...  
2011 ◽  
Vol 10 (4) ◽  
pp. 2113-2122 ◽  
Author(s):  
Ulla Seppälä ◽  
Claire Dauly ◽  
Sarah Robinson ◽  
Martin Hornshaw ◽  
Jørgen Nedergaard Larsen ◽  
...  

2020 ◽  
Vol 21 (2) ◽  
pp. 203-223 ◽  
Author(s):  
Alain Jacquet

Allergen-specific Immunotherapy (AIT), through repetitive subcutaneous or sublingual administrations of allergen extracts, represents up to now the unique treatment against allergic sensitizations. However, the clinical efficacy of AIT can be largely dependent on the quality of natural allergen extracts. Moreover, the long duration and adverse side effects associated with AIT negatively impact patient adherence. Tremendous progress in the field of molecular allergology has made possible the design of safer, shorter and more effective new immunotherapeutic approaches based on purified and characterized natural or recombinant allergen derivatives and peptides. This review will summarize the characteristics of these different innovative vaccines including their effects in preclinical studies and clinical trials.


2016 ◽  
Vol 137 (5) ◽  
pp. 1535-1544 ◽  
Author(s):  
Mattias Levin ◽  
Jasmine J. King ◽  
Jacob Glanville ◽  
Katherine J.L. Jackson ◽  
Timothy J. Looney ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document